Brief: Arch Biopartners announces issuance of U.S. patent for Metablok
11/10/2016 14:07
Oct 11 (Reuters) - Arch Biopartners Inc ACH.V :
* Arch Biopartners announces issuance of U.S. patent for
Metablok
Source text for Eikon: ID:nCCN1sF9Zs
Further company coverage: ACH.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide